Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The type of anti-inflammatory medication used post selective laser trabeculoplasty (SLT) may
have an impact on the intra-ocular pressure (IOP) lowering effect of SLT. This study will
evaluate the IOP lowering effect of SLT following the topical administration of one of the
following: prednisolone 1%, ketorolac 0.5% or artificial tears.